Skip to main content
Equibles
NVST logo

NVST · Envista Holdings Corp

Track NVST — free

Use NVST with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$27.28 -0.31 (-1.12%) At close · Sep 4
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$4.38B
Shares
160.62M

NVST metrics

84 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$27.28
Market cap
$4.38B

Price action

19 metrics
Price change (1W)
+0.6%
Price change (30D)
-3.2%
Price change (3M)
+18.1%
Price change (6M)
+1.6%
Price change (YTD)
+25.7%
Price change (1Y)
+31.3%
Trailing year
Price change (5Y)
-37.1%
52-week high
$30.26
52-week low
$18.95
Change from 52-week high
-9.8%
Change from 52-week low
+44.0%
Annualized volatility
37.4%
Beta
1.3
RSI (14D)
49.3
Price vs SMA 50
+0.2%
Price vs SMA 200
+7.8%
Avg volume (3M)
2.68M
Relative volume
0.6
Average dollar volume
$71.79M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
160.62M

Valuation

12 metrics
P / E (TTM)
47.0
Trailing earnings · reciprocal yield 2.1%
PEG ratio
0.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 65.2%
P / book
1.4
reciprocal yield 70.2%
FCF yield
5.7%
TTM · current market cap
Buyback yield
—
P / FCF
17.7
reciprocal yield 5.7%
P / operating cash flow
14.5
reciprocal yield 6.9%
Earnings yield
2.2%

Historical valuation

8 metrics
P / E historical average (3Y)
92.0×
reciprocal yield 1.1%
P / E historical average (5Y)
65.9×
reciprocal yield 1.5%
EV / revenue historical average (3Y)
1.5×
reciprocal yield 64.8%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 49.6%
EV / EBIT historical average (3Y)
98.0×
reciprocal yield 1.0%
EV / EBIT historical average (5Y)
60.3×
reciprocal yield 1.7%
EV / EBITDA historical average (3Y)
13.1×
reciprocal yield 7.7%
EV / EBITDA historical average (5Y)
13.1×
reciprocal yield 7.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
55.2%
Operating margin
9.6%
Trailing 12 months
Net margin
3.3%
Gross profit (TTM)
$1.58B
Operating profit (TTM)
$273.60M
Net income (TTM)
$95.00M
Trailing 12 months
Diluted EPS (TTM)
$0.58
FCF margin
8.7%
Effective tax rate
59.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$48,231,000.00

Growth

11 metrics
Revenue growth YoY
+7.1%
Year over year
Net income growth YoY
+103.4%
Revenue (TTM)
$2.86B
Trailing 12 months
EPS growth YoY
+106.3%
Shares change YoY
-3.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+1.9%
Revenue CAGR (5Y)
+7.1%
EPS CAGR (3Y)
-41.1%
EPS CAGR (5Y)
+7.0%
FCF CAGR (3Y)
+29.1%
FCF CAGR (5Y)
-0.5%

Quality

14 metrics
Return on equity
3.1%
Return on assets
1.7%
Debt / equity
—
Current ratio
2.4
EBITDA (TTM)
$388.90M
Free cash flow (TTM)
$248.10M
Quick ratio
2.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.13B
Total assets
$5.60B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$302.60M
Capital expenditures (TTM)
$54.50M
R&D (TTM)
$120.80M
SG&A (TTM)
$1.18B
Stock compensation (TTM)
$40.50M
R&D / revenue
4.2%
Stock compensation / revenue
1.4%

Ownership (13F)

3 metrics
13F filers
383
13F filer change QoQ
-9
Institutional ownership
118.3%

Short interest

3 metrics
Short interest
6.0%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$220,000
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1757073 CUSIP 29415F104 13F (30d) 223 filings 222 filers Visit website Investor relations